Solaris Infusion

What is Soliris?

Soliris (Eculizumab) is a revolutionary treatment for people suffering from different blood disorders, immune dysfunction, muscle, and nervous system disorder. It is a prescription medication containing monoclonal antibodies used to treat health conditions in both adult and adolescent patients, only after the doctor's approval,

Soliris treatment is one of the most effective medications for immunotherapy. It works by suppressing the immune system of the body and thereby decreases the activity of the body's defense mechanism against its healthy cells. It works unlike other immunosuppressant drugs; and has shown more impressive results and may help slow down the disease progression or development of new or worsening symptoms.

915-808-0006

Request a Call Back

What Does Soliris Infusion Treat?

Soliris Infusion is a prescription infusion medication that is advised after careful diagnosis by the health professionals to treat the patients having serious illnesses like certain immune disorders and neurological complaints. Though it has a wide range of benefits in treating serious medical conditions, a health care professional must do a deep study and diagnosis of each patient's medical history.

Soliris therapy is a promising treatment of choice for the treatment of the following autoimmune disorders;

  • Neuromyelitis Optica Spectrum Disorder NMOSD
  • Paroxysmal Nocturnal Hemoglobinuria PNH
  • Atypical Hemolytic Uremic Syndrome AHUS
  • Generalized Myasthenia Gravis GMG

Neuromyelitis Optica Spectrum Disorder NMOSD

A certain nervous system disorder, the primary target of which is an individual's eye or the optical nerves. It usually occurs when the body's immune cells destroy nerve cells in the spinal cord and the eyes. It can alter the normal functioning of the nerve cells in the eyes, causing blindness or blurred vision. It is also known to cause recurrent muscle spasms by impairing the spinal cord nerves.

Paroxysmal Nocturnal Hemoglobinuria PNH

It is a rare acquired autoimmune disorder of the blood. It is characterized by blood clotting and the breakdown of the red blood cells (hemolysis), leading to a significant reduction in their number that ultimately causes Anemia.

Atypical Hemolytic Uremic Syndrome AHUS

Complement-mediated thrombotic microangiopathy (TMA) or Hemolytic Uremic Syndrome is a disorder of the immune system in which the blood clots appear and clog the blood vessels in the kidneys, ultimately causing renal/kidney failure. Kidney damage, in turn, can lead to other possible complications like blood pressure and may generate sensitivity toward several fatal or serious infections.

Generalized Myasthenia Gravis GMG

Myasthenia gravis is an autoimmune disorder that affects the neuromuscular functioning of the body altogether. It impairs the nerve cell's connection with the skeletal muscles, resulting in muscle weakness and fatigue. The lost neuromuscular connectivity is often exacerbated and makes it difficult for individuals to swallow and breathe. Soliris acts as an inhibitor for the acetylcholine receptor ACHR antibody, the main factor in the adult patient's immune system that causes GMG.

How Does Soliris Work?

Soliris treatment is based on the monoclonal antibodies that act as immunosuppressants. It performs its activity by binding and inhibiting certain antibodies of the immune system, whose activity triggers the action of the body's defense mechanism against its healthy cells. For instance, it effectively binds to the protein (a component in the blood that destroys the red blood cells) and helps improve and overcome the symptoms of paroxysmal nocturnal hemoglobinuria and avoid repeated blood transfusions sessions.

Benefits of Soliris Infusion

Infusing Soliris into patients with disorders of blood, nervous system and muscles, is a promising new treatment that may delay or prevent the progression of their condition. Infusions can be repeated every few weeks, depending on the doctor's instructions and how well a patient responds to the treatment with Soliris.

Due to its many benefits, it is used as a treatment option for patients.

  • Soliris is an option for those who have failed to respond or cannot tolerate other treatments.
  • This drug has been shown to significantly reduce the symptoms, as well as provide some relief during them when they do happen.
  • It also improves the quality of life for many people who take this medicine as per the schedule.
  • It is also done through a series of infusions which means you don't need daily pill-taking as some medications do!

Important Information About Soliris

The healthcare professionals and researchers at Alexion agree that treatment with Soliris has positive results in combating certain critical autoimmune diseases. However, Soliris has to be used with extreme caution and should only be initiated after a doctor's prescription, as reported, Soliris-treated patients have an increased risk of meningococcal infection.

Before initiating the Soliris infusion therapy certain facts should be kept into consideration, like getting enrolled in the Soliris REMS program (Risk Evaluation and Mitigation Strategy). Our healthcare professionals at Vitamind Infusion Center will guide you through all the necessary precautions to ensure the safe and effective use of Soliris;

  • Immunosuppressant Activity of Soliris

    It is a well-established fact that Soliris (Eculizumab) directly affects your immune system. It suppresses the activity of the first line defender cells by inhibiting their receptor sites. Hence, it may increase the susceptibility of patients to retract other infections like meningococcal infections or fungal infections.
  • Meningococcal Vaccines

    Meningococcal infection risk is enhanced in the patients treated with Soliris; therefore, it is advised that the patients seeking Soliris should have meningococcal vaccination at least 2 weeks before the initial Soliris dose. The meningococcal vaccines reduce the chances of getting infected with meningitis infection.
  • Other Medical Conditions

    It is advised to the patients who are thinking of Soliris program infusion to be open and honest towards their doctor. Tell your doctor about any underlying medical conditions like upper respiratory tract infection, allergic reactions, hypersensitivity reactions, or any other serious infection.
  • Drug Associated Risk

    Patients must inform the healthcare professional about the ongoing use of other drugs and any vaccinations taken, to avoid any possible drug interactions with Soliris, leading to severe symptoms.
  • Pregnancy or Lactation

    Pregnant or breastfeeding women must get their doctors' advice before initiating the treatment with Tysabri, as there is less or little known data about the release of Tysabri in breast milk or its effects on the fetus.

Who Should Not Get Soliris Infusion Therapy?

You must not go for Soliris infusion if you have any one of the following conditions,

  • Immunocompromised and neutropenic patients
  • Individuals suffering from life-threatening meningococcal infections
  • Individuals who did not receive meningococcal vaccination
  • Individuals reported having allergic reactions
  • Individuals having any other severe infection present or in the near past.

What to expect from IV Soliris Infusion?

Soliris is administered by diluting the medicine into the infusion. The recommended dose for an individual is highly specific to the patient's condition, body response, age, or body weight.

The therapy may constitute several infusion sessions paced over several weeks depending upon the condition of an individual or how quickly his symptoms recede. However, the dosing schedule for a patient is dependent on the medical condition of an adult or a children's body weight.

The therapy usually lasts for 45 minutes to an hour. The initial dose is generally continued for 7 days for the first 5 weeks and then it may change or only require to be given fortnightly. During or after an hour of the treatment, a nurse will constantly monitor the patients and check their vitals to keep them stable or call for emergency medical care if immediate medical attention is needed.

A patient safety card is handed to each client to keep a track of any side effects that may appear as a result of the ongoing therapy with Soliris, and, they may need to keep it with them for three to twelve months after the last Soliris dose.

Soliris Infusion in EL Paso, TX

Vitamind Infusion Center in El Paso, TX, provides medically-prescribed infusion treatment for individuals who have autoimmune disorders like Neuromyelitis Optica Spectrum Disorder, Paroxysmal Nocturnal Hemoglobinuria, Atypical Hemolytic Uremic Syndrome, and Refractory Generalized Myasthenia Gravis in a warm and welcoming environment. Our technical staff is trained to work closely with patients to customize the treatment plan for each patient. Once the developmental and health benefits profile of Soliris, for an individual, outweighs all other conditions then our health team proceeds with the Soliris Infusion Therapy.

Our team of healthcare providers is devoted to making your experience as pleasant as possible. Before beginning any treatment, we always notify our patients about any potential side effects and answer all of their concerns regarding the treatment.

Book Your Appointment

Solaris Infusion

Let's Meet

You do not need a physician referral to visit the Vitamind Infusion Center.

We provide immune support infusion services in El Paso, Tx, and the surrounding areas, and also provide help and care to international patients. If you'd like to schedule a consultation with one of our specialists, the best way to do so is to call us during business hours. Or, you can fill out the form here to book an appointment online.

2311 N MESA STREET SUITE AEL PASO TX 79902BOOK A TREATMENT: 915-808-0006

Frequently Asked Questions FAQs

Some of the most common questions asked about Solaris Infusion

Soliris is used to treat a series of autoimmune disorders that may be characterized by a blood disorder, neurological disorders, or certain muscle dysfunctions. The conditions that Soliris infusion can treat with promising results are; Neuromyelitis Optica Spectrum Disorder, Paroxysmal Nocturnal Hemoglobinuria PNH, Atypical Hemolytic Uremic Syndrome AHUS, and Generalized Myasthenia Gravis GMG.

The duration of a Soliris infusion typically lasts an hour or less. Series of infusion sessions may continue for several weeks initially at a rate of one dose per week then may gradually change to a dose given fortnightly. However, it is to be noted that the dose and session of a Soliris infusion are highly specific to an individual patient.

Always follow the dosing schedule as prescribed to you. In case of a missed dose, consult or contact your doctor for the right guidance. Care should always be taken while being treated with Soliris as it requires regular monitoring over several weeks to avoid the emergence of any unwanted adverse reactions.

Seek emergency medical attention or call the Poison control center. However, it is recommended to take some professional help for your Soliris infusion therapy as it requires the technical expertise of the qualified staff who are specifically trained to deal in Soliris treatment

You should avoid the use of Soliris if you have a known allergic reaction to the use of it or if you have a meningococcal infection or did not have a meningococcal vaccine. Avoid use if you have any severe infection or underlying serious and life-threatening medical condition that may exacerbate due to the immunosuppressant action of Soliris.

Patients treated with Soliris must receive meningococcal vaccines before initiating the treatment to avoid extracting serious meningococcal infections. To prevent the risk of meningococcal infection one must administer the meningococcal vaccine at least two weeks before starting the treatment with Soliris.

Frequently Asked Questions FAQs

What is Soliris infusion used to treat?
Soliris is used to treat a series of autoimmune disorders that may be characterized by a blood disorder, neurological disorders, or certain muscle dysfunctions. The conditions that Soliris infusion can treat with promising results are; Neuromyelitis Optica Spectrum Disorder, Paroxysmal Nocturnal Hemoglobinuria PNH, Atypical Hemolytic Uremic Syndrome AHUS, and Generalized Myasthenia Gravis GMG.
How long is a Soliris Infusion?

The duration of a Soliris infusion typically lasts an hour or less. Series of infusion sessions may continue for several weeks initially at a rate of one dose per week then may gradually change to a dose given fortnightly. However, it is to be noted that the dose and session of a Soliris infusion are highly specific to an individual patient.

What happens if I miss a dose?
Always follow the dosing schedule as prescribed to you. In case of a missed dose, consult or contact your doctor for the right guidance. Care should always be taken while being treated with Soliris as it requires regular monitoring over several weeks to avoid the emergence of any unwanted adverse reactions.
What happens if I overdose?
Seek emergency medical attention or call the Poison control center. However, it is recommended to take some professional help for your Soliris infusion therapy as it requires the technical expertise of the qualified staff who are specifically trained to deal in Soliris treatment
When should I avoid Soliris?
You should avoid the use of Soliris if you have a known allergic reaction to the use of it or if you have a meningococcal infection or did not have a meningococcal vaccine. Avoid use if you have any severe infection or underlying serious and life-threatening medical condition that may exacerbate due to the immunosuppressant action of Soliris.
Is there a risk of meningococcal infection with the Soliris rems program?
Patients treated with Soliris must receive meningococcal vaccines before initiating the treatment to avoid extracting serious meningococcal infections. To prevent the risk of meningococcal infection one must administer the meningococcal vaccine at least two weeks before starting the treatment with Soliris.